Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life

perjantai 14. maaliskuuta 2014 päivittänyt: Boehringer Ingelheim
The study will compare the effect of pramipexole on different types of tremor and particularly kinetic tremor in early and advanced Parkinson's disease patients and will evaluate the course of tremor measured with spiralometry under pramipexole treatment.

Tutkimuksen yleiskatsaus

Tila

Valmis

Ehdot

Opintotyyppi

Havainnollistava

Ilmoittautuminen (Todellinen)

1703

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

  • Latvia
      • Kuldiga, Latvia
        • Boehringer Ingelheim Investigational Site 9
      • Liepaja, Latvia
        • Boehringer Ingelheim Investigational Site 12
      • Liepaja, Latvia
        • Boehringer Ingelheim Investigational Site 13
      • Liepaja, Latvia
        • Boehringer Ingelheim Investigational Site 14
      • Liepaja, Latvia
        • Boehringer Ingelheim Investigational Site 15
      • Limbazi, Latvia
        • Boehringer Ingelheim Investigational Site 10
      • Limbazi, Latvia
        • Boehringer Ingelheim Investigational Site 11
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 16
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 17
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 18
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 19
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 20
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 21
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 22
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 23
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 24
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 25
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 26
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 27
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 28
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 29
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 30
      • Riga, Latvia
        • Boehringer Ingelheim Investigational Site 31
  • Romania
      • Aiud, Romania
        • Boehringer Ingelheim Investigational Site 32
      • Arges, Romania
        • Boehringer Ingelheim Investigational Site 33
      • Arges, Romania
        • Boehringer Ingelheim Investigational Site 34
      • Arges, Romania
        • Boehringer Ingelheim Investigational Site 35
      • Arges, Romania
        • Boehringer Ingelheim Investigational Site 36
      • Arges, Romania
        • Boehringer Ingelheim Investigational Site 37
      • Arges, Romania
        • Boehringer Ingelheim Investigational Site 38
      • Arges, Romania
        • Boehringer Ingelheim Investigational Site 39
      • Bacau, Romania
        • Boehringer Ingelheim Investigational Site 40
      • Bacau, Romania
        • Boehringer Ingelheim Investigational Site 41
      • Bistrita, Romania
        • Boehringer Ingelheim Investigational Site 42
      • Botosani, Romania
        • Boehringer Ingelheim Investigational Site 43
      • Botosani, Romania
        • Boehringer Ingelheim Investigational Site 44
      • Braila, Romania
        • Boehringer Ingelheim Investigational Site 45
      • Braila, Romania
        • Boehringer Ingelheim Investigational Site 46
      • Brasov, Romania
        • Boehringer Ingelheim Investigational Site 47
      • Brasov, Romania
        • Boehringer Ingelheim Investigational Site 48
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 49
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 50
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 51
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 52
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 53
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 54
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 55
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 56
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 57
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 58
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 59
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 60
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 61
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 62
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 63
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 64
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 65
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 66
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 67
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 68
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 69
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 70
      • Bucuresti, Romania
        • Boehringer Ingelheim Investigational Site 71
      • Buzau, Romania
        • Boehringer Ingelheim Investigational Site 72
      • Buzau, Romania
        • Boehringer Ingelheim Investigational Site 73
      • Caracal, Romania
        • Boehringer Ingelheim Investigational Site 74
      • Cluj, Romania
        • Boehringer Ingelheim Investigational Site 75
      • Cluj, Romania
        • Boehringer Ingelheim Investigational Site 76
      • Cluj, Romania
        • Boehringer Ingelheim Investigational Site 77
      • Cluj, Romania
        • Boehringer Ingelheim Investigational Site 78
      • Cluj, Romania
        • Boehringer Ingelheim Investigational Site 79
      • Cluj, Romania
        • Boehringer Ingelheim Investigational Site 80
      • Constanta, Romania
        • Boehringer Ingelheim Investigational Site 81
      • Constanta, Romania
        • Boehringer Ingelheim Investigational Site 82
      • Craiova, Romania
        • Boehringer Ingelheim Investigational Site 83
      • Craiova, Romania
        • Boehringer Ingelheim Investigational Site 84
      • Craiova, Romania
        • Boehringer Ingelheim Investigational Site 85
      • Craiova, Romania
        • Boehringer Ingelheim Investigational Site 86
      • Deva, Romania
        • Boehringer Ingelheim Investigational Site 87
      • Deva, Romania
        • Boehringer Ingelheim Investigational Site 88
      • Focsani, Romania
        • Boehringer Ingelheim Investigational Site 89
      • Focsani, Romania
        • Boehringer Ingelheim Investigational Site 90
      • Galati, Romania
        • Boehringer Ingelheim Investigational Site 91
      • Galati, Romania
        • Boehringer Ingelheim Investigational Site 92
      • Hunedoara, Romania
        • Boehringer Ingelheim Investigational Site 93
      • Hunedoara, Romania
        • Boehringer Ingelheim Investigational Site 94
      • Iasi, Romania
        • Boehringer Ingelheim Investigational Site 95
      • Iasi, Romania
        • Boehringer Ingelheim Investigational Site 96
      • Iasi, Romania
        • Boehringer Ingelheim Investigational Site 97
      • Iasi, Romania
        • Boehringer Ingelheim Investigational Site 98
      • Lugoj, Romania
        • Boehringer Ingelheim Investigational Site 99
      • Maramures, Romania
        • Boehringer Ingelheim Investigational Site 100
      • Orastie, Romania
        • Boehringer Ingelheim Investigational Site 101
      • Pascani, Romania
        • Boehringer Ingelheim Investigational Site 102
      • Pascani, Romania
        • Boehringer Ingelheim Investigational Site 103
      • Petrosani, Romania
        • Boehringer Ingelheim Investigational Site 104
      • Piatra Neamt, Romania
        • Boehringer Ingelheim Investigational Site 105
      • Prahova, Romania
        • Boehringer Ingelheim Investigational Site 106
      • Prahova, Romania
        • Boehringer Ingelheim Investigational Site 107
      • Prahova, Romania
        • Boehringer Ingelheim Investigational Site 108
      • Radauti, Romania
        • Boehringer Ingelheim Investigational Site 109
      • Resita, Romania
        • Boehringer Ingelheim Investigational Site 110
      • Satu Mare, Romania
        • Boehringer Ingelheim Investigational Site 111
      • Sibiu, Romania
        • Boehringer Ingelheim Investigational Site 112
      • Sibiu, Romania
        • Boehringer Ingelheim Investigational Site 113
      • Slatina, Romania
        • Boehringer Ingelheim Investigational Site 114
      • Suceava, Romania
        • Boehringer Ingelheim Investigational Site 115
      • Suceava, Romania
        • Boehringer Ingelheim Investigational Site 116
      • Teleorman, Romania
        • Boehringer Ingelheim Investigational Site 117
      • Tg. Mures, Romania
        • Boehringer Ingelheim Investigational Site 118
      • Timisoara, Romania
        • Boehringer Ingelheim Investigational Site 119
      • Timisoara, Romania
        • Boehringer Ingelheim Investigational Site 120
      • Timisoara, Romania
        • Boehringer Ingelheim Investigational Site 121
      • Timisoara, Romania
        • Boehringer Ingelheim Investigational Site 122
      • Tulcea, Romania
        • Boehringer Ingelheim Investigational Site 123
      • Tulcea, Romania
        • Boehringer Ingelheim Investigational Site 124
  • Serbia
      • Belgrade, Serbia
        • Boehringer Ingelheim Investigational Site 135
      • Belgrade, Serbia
        • Boehringer Ingelheim Investigational Site 136
      • Kragujevac, Serbia
        • Boehringer Ingelheim Investigational Site 140
      • Krusevac, Serbia
        • Boehringer Ingelheim Investigational Site 138
      • Nis, Serbia
        • Boehringer Ingelheim Investigational Site 141
      • Nis, Serbia
        • Boehringer Ingelheim Investigational Site 142
      • Novi Sad, Serbia
        • Boehringer Ingelheim Investigational Site 137
      • Sombor, Serbia
        • Boehringer Ingelheim Investigational Site 143
      • Uzice, Serbia
        • Boehringer Ingelheim Investigational Site 145
      • Valjevo, Serbia
        • Boehringer Ingelheim Investigational Site 139
      • Vranje, Serbia
        • Boehringer Ingelheim Investigational Site 144
  • Slovakia
      • ?adca, Slovakia
        • Boehringer Ingelheim Investigational Site 155
      • Banská Bystrica, Slovakia
        • Boehringer Ingelheim Investigational Site 146
      • Bardejov, Slovakia
        • Boehringer Ingelheim Investigational Site 147
      • Bratislava, Slovakia
        • Boehringer Ingelheim Investigational Site 148
      • Bratislava, Slovakia
        • Boehringer Ingelheim Investigational Site 149
      • Bratislava, Slovakia
        • Boehringer Ingelheim Investigational Site 150
      • Bratislava, Slovakia
        • Boehringer Ingelheim Investigational Site 151
      • Bratislava, Slovakia
        • Boehringer Ingelheim Investigational Site 152
      • Bratislava, Slovakia
        • Boehringer Ingelheim Investigational Site 153
      • Brezno, Slovakia
        • Boehringer Ingelheim Investigational Site 154
      • Humenné, Slovakia
        • Boehringer Ingelheim Investigational Site 156
      • Ilava, Slovakia
        • Boehringer Ingelheim Investigational Site 157
      • Komárno, Slovakia
        • Boehringer Ingelheim Investigational Site 158
      • Kosice, Slovakia
        • Boehringer Ingelheim Investigational Site 159
      • Kosice, Slovakia
        • Boehringer Ingelheim Investigational Site 160
      • Kosice, Slovakia
        • Boehringer Ingelheim Investigational Site 161
      • Kosice, Slovakia
        • Boehringer Ingelheim Investigational Site 162
      • Kosice- Saca, Slovakia
        • Boehringer Ingelheim Investigational Site 163
      • Krompachy, Slovakia
        • Boehringer Ingelheim Investigational Site 164
      • Levice, Slovakia
        • Boehringer Ingelheim Investigational Site 165
      • Liptovský Mikulás, Slovakia
        • Boehringer Ingelheim Investigational Site 166
      • Lucenec, Slovakia
        • Boehringer Ingelheim Investigational Site 167
      • Martin, Slovakia
        • Boehringer Ingelheim Investigational Site 168
      • Nitra, Slovakia
        • Boehringer Ingelheim Investigational Site 169
      • Nitra, Slovakia
        • Boehringer Ingelheim Investigational Site 170
      • Nitra, Slovakia
        • Boehringer Ingelheim Investigational Site 171
      • Nováky, Slovakia
        • Boehringer Ingelheim Investigational Site 172
      • Nové Mesto n/ Váhom, Slovakia
        • Boehringer Ingelheim Investigational Site 173
      • Pezinok, Slovakia
        • Boehringer Ingelheim Investigational Site 174
      • Pies?any, Slovakia
        • Boehringer Ingelheim Investigational Site 175
      • Povazská Bystrica, Slovakia
        • Boehringer Ingelheim Investigational Site 176
      • Presov, Slovakia
        • Boehringer Ingelheim Investigational Site 177
      • Presov, Slovakia
        • Boehringer Ingelheim Investigational Site 178
      • Presov, Slovakia
        • Boehringer Ingelheim Investigational Site 179
      • Revúca, Slovakia
        • Boehringer Ingelheim Investigational Site 180
      • Rimavská Sobota, Slovakia
        • Boehringer Ingelheim Investigational Site 181
      • Roznava, Slovakia
        • Boehringer Ingelheim Investigational Site 182
      • Roznava, Slovakia
        • Boehringer Ingelheim Investigational Site 183
      • Sal'a, Slovakia
        • Boehringer Ingelheim Investigational Site 184
      • Sered, Slovakia
        • Boehringer Ingelheim Investigational Site 185
      • Skalica, Slovakia
        • Boehringer Ingelheim Investigational Site 186
      • Stropkov, Slovakia
        • Boehringer Ingelheim Investigational Site 187
      • Surany, Slovakia
        • Boehringer Ingelheim Investigational Site 188
      • Trebisov, Slovakia
        • Boehringer Ingelheim Investigational Site 189
      • Tren?in, Slovakia
        • Boehringer Ingelheim Investigational Site 190
      • Trnava, Slovakia
        • Boehringer Ingelheim Investigational Site 191
      • Trnava, Slovakia
        • Boehringer Ingelheim Investigational Site 192
      • Trstená, Slovakia
        • Boehringer Ingelheim Investigational Site 193
      • Vel'ke Kapusany, Slovakia
        • Boehringer Ingelheim Investigational Site 194
      • Ziar N/Hronom, Slovakia
        • Boehringer Ingelheim Investigational Site 195
      • Zilina, Slovakia
        • Boehringer Ingelheim Investigational Site 196
      • Zilina, Slovakia
        • Boehringer Ingelheim Investigational Site 197
      • Zlaté Moravce, Slovakia
        • Boehringer Ingelheim Investigational Site 198
      • Zvolen, Slovakia
        • Boehringer Ingelheim Investigational Site 199
      • Zvolen, Slovakia
        • Boehringer Ingelheim Investigational Site 200
  • Slovenia
      • Bled, Slovenia
        • Boehringer Ingelheim Investigational Site 205
      • Celje, Slovenia
        • Boehringer Ingelheim Investigational Site 206
      • Ljubljana, Slovenia
        • Boehringer Ingelheim Investigational Site 201
      • Ljubljana, Slovenia
        • Boehringer Ingelheim Investigational Site 202
      • Maribor, Slovenia
        • Boehringer Ingelheim Investigational Site 207
      • Maribor, Slovenia
        • Boehringer Ingelheim Investigational Site 208
      • Maribor, Slovenia
        • Boehringer Ingelheim Investigational Site 209
      • Maribor, Slovenia
        • Boehringer Ingelheim Investigational Site 210
      • Sempeter pri Gorici, Slovenia
        • Boehringer Ingelheim Investigational Site 203
      • Sempeter pri Gorici, Slovenia
        • Boehringer Ingelheim Investigational Site 204
  • Ukraina
      • Kharkiv, Ukraina
        • Boehringer Ingelheim Investigational Site 212
      • Kyiv, Ukraina
        • Boehringer Ingelheim Investigational Site 211
      • Lviv, Ukraina
        • Boehringer Ingelheim Investigational Site 215
      • Ternopil, Ukraina
        • Boehringer Ingelheim Investigational Site 214
      • Vinnitsa, Ukraina
        • Boehringer Ingelheim Investigational Site 213
  • Venäjän federaatio
      • Krasnodar, Venäjän federaatio
        • Boehringer Ingelheim Investigational Site 131
      • Krasnoyarsk, Venäjän federaatio
        • Boehringer Ingelheim Investigational Site 130
      • Moscow, Venäjän federaatio
        • Boehringer Ingelheim Investigational Site 125
      • Moscow, Venäjän federaatio
        • Boehringer Ingelheim Investigational Site 126
      • Moscow, Venäjän federaatio
        • Boehringer Ingelheim Investigational Site 127
      • Novosibirsk, Venäjän federaatio
        • Boehringer Ingelheim Investigational Site 128
      • Saint-Petersburg, Venäjän federaatio
        • Boehringer Ingelheim Investigational Site 132
      • Saint-Petersburg, Venäjän federaatio
        • Boehringer Ingelheim Investigational Site 133
      • Saint-Petersburg, Venäjän federaatio
        • Boehringer Ingelheim Investigational Site 134
      • Tomsk, Venäjän federaatio
        • Boehringer Ingelheim Investigational Site 129
  • Viro
      • Keila, Viro
        • Boehringer Ingelheim Investigational Site 5
      • Kohtla-Järve, Viro
        • Boehringer Ingelheim Investigational Site 4
      • Rakvere, Viro
        • Boehringer Ingelheim Investigational Site 6
      • Tallinn, Viro
        • Boehringer Ingelheim Investigational Site 1
      • Tallinn, Viro
        • Boehringer Ingelheim Investigational Site 2
      • Tallinn, Viro
        • Boehringer Ingelheim Investigational Site 3
      • Tartu, Viro
        • Boehringer Ingelheim Investigational Site 7
      • Valga, Viro
        • Boehringer Ingelheim Investigational Site 8

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

  • Lapsi
  • Aikuinen
  • Vanhempi Aikuinen

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Näytteenottomenetelmä

Ei-todennäköisyysnäyte

Tutkimusväestö

Neurologists

Kuvaus

Inclusion Criteria:

  1. Idiopathic Parkinson's disease with or without fluctuations
  2. Indication for treatment with pramipexole (Mirapexin®)
  3. Presence of at least mild tremor symptoms (as judged by the treating physician)

Exclusion Criteria:

  1. Any contraindications according to the Summary of Product Characteristics (SPC): hypersensitivity to pramipexole or to any of the excipients.
  2. Ongoing treatment with pramipexole (Mirapexin®)

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

Kohortit ja interventiot

Ryhmä/Kohortti
Patients with Parkinson's disease
Early and advanced Parkinson's disease patients

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Change From Baseline in Unified Parkinson's Disease Rating Scale (UPDRS) Part II Score at the End of Maintenance
Aikaikkuna: Week 0 to weeks 9-16 (Visit 3)
Change (reduction) in UPDRS Part II score (activities of daily living) from baseline to end of study. Score ranging from 0 - 52 (0=no disability, 52=maximum disability)
Week 0 to weeks 9-16 (Visit 3)
Change From Baseline in UPDRS Part III Score at the End of Maintenance
Aikaikkuna: Week 0 to weeks 9-16
Change (reduction) in UPDRS Part III score (motor function) from baseline to end of study. Score ranging from 0 - 108 (0=no disability, 108=maximum disability)
Week 0 to weeks 9-16
Change From Baseline in Spiralometry Measurement at the End of Maintenance (Right Hand)
Aikaikkuna: Week 0 to weeks 9-16 (Visit 3)
Change (reduction) in tremor amplitude from baseline to end of study for the right hand
Week 0 to weeks 9-16 (Visit 3)
Change From Baseline in Spiralometry Measurement at the End of Maintenance (Left Hand)
Aikaikkuna: Week 0 to weeks 9-16 (Visit 3)
Change (reduction) in tremor amplitude from baseline to end of study for the left hand
Week 0 to weeks 9-16 (Visit 3)
Change From Baseline in Tremor Score From UPDRS (Items 16, 20, 21) at the End of Maintenance (Visit 3)
Aikaikkuna: Week 0 to weeks 9-16 (Visit 3)
Change (reduction)in tremor score from baseline to end of study. Score ranging from 0 - 32 (0=no tremor, 32=high tremor)
Week 0 to weeks 9-16 (Visit 3)
Change From Baseline in 39 Item Parkinson's Disease Questionnaire (PDQ-39) Score at the End of Maintenance
Aikaikkuna: Week 0 to weeks 9-16 (Visit 3)
Change (reduction) in PDQ-39 score (quality of life) from baseline to end of study. Score ranging from 0-100 (0=perfect health, 100=worst health as assessed by the measure)
Week 0 to weeks 9-16 (Visit 3)

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Final Dose Distribution
Aikaikkuna: Enter Week 0 to weeks 9-16 (Visit 3)
Final Mirapexin® dose distribution at the end of study
Enter Week 0 to weeks 9-16 (Visit 3)
Change From Baseline in UPDRS Part II Score at the End of Up-titration
Aikaikkuna: Enter Week 0 to weeks 1-8 (Visit 2)
Change (reduction) in UPDRS Part II score (activities of daily living) from baseline to Visit 2. Score ranging from 0 - 52 (0=no disability, 52=maximum disability)
Enter Week 0 to weeks 1-8 (Visit 2)
Change From Baseline in UPDRS Part III Score at the End of Up-titration
Aikaikkuna: Enter Week 0 to weeks 1-8 (Visit 2)
Change (reduction) in UPDRS Part III score (motor function) from baseline to Visit 2. Score ranging from 0 - 108 (0=no disability, 108=maximum disability)
Enter Week 0 to weeks 1-8 (Visit 2)
Change in Tremor Score (UPDRS Items 16, 20, 21) at the End of Up-titration
Aikaikkuna: Enter Week 0 to weeks 1-8 (Visit 2)
Change (reduction) from baseline in tremor score, derived from UPDRS from baseline to Visit 2. Score ranging from 0 - 32 (0=no tremor, 32=high tremor)
Enter Week 0 to weeks 1-8 (Visit 2)
Incidence, Relationship and Seriousness of Adverse Events
Aikaikkuna: Week 0 to weeks 9-16 (end of study)
Total number of adverse events (AEs), causality and level of seriousness
Week 0 to weeks 9-16 (end of study)
Number of Premature Discontinuations
Aikaikkuna: Week 0 to weeks 9-16 (end of study)
Number of patients discontinuing the study prematurely
Week 0 to weeks 9-16 (end of study)

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Sponsori

Boehringer Ingelheim

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Hyödyllisiä linkkejä

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus

Perjantai 1. helmikuuta 2008

Ensisijainen valmistuminen (Todellinen)

Lauantai 1. elokuuta 2009

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Torstai 18. maaliskuuta 2010

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Keskiviikko 7. huhtikuuta 2010

Ensimmäinen Lähetetty (Arvio)

Torstai 8. huhtikuuta 2010

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Arvio)

Perjantai 11. huhtikuuta 2014

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Perjantai 14. maaliskuuta 2014

Viimeksi vahvistettu

Lauantai 1. maaliskuuta 2014

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muita asiaankuuluvia MeSH-ehtoja

Muut tutkimustunnusnumerot

  • 248.657

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa